Nanobio and Nanomedicine

A nanotechnology licensing company that provides custom engineered chemical treatments using nano-scale infusion technologies that are configured to the unique requirements of a variety of industrial applications.

Calando combines proprietary technologies in targeted polymeric nanoparticle delivery systems and siRNA design to create effective therapeutics.

The company's Gemini™ biomarker discovery platform combines high-resolution electrokinetic focusing of peptides and nanoscale reversed-phase liquid chromatography.

A leading provider of cutting-edge technologies enabling researchers in the life sciences to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper has compiled numerous best-in-class solutions and is aggressively innovating new technologies to bridge the gaps that exist in bringing in vitro assays to in vivo results and ultimately into cures for human disease.

Camurus specializes in the development of pharmaceuticals based on advanced and effective innovative nanoscale drug delivery systems that optimize the bioavailability and therapeutic performance of a wide range of difficult substances, including: peptides, proteins, and insoluble small molecules.

Develops nanotechnology-based advanced drug delivery carriers, medical devices and diagnostic particles.

A a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. The company's sensors are designed and manufactured using microelectromechanical systems, or MEMS, technology, which enables the fabrication of millimeter-scale devices with internal features in the nanometer to micrometer range.

Carestream Molecular Imaging is a leading provider of Kodak branded in vivo and in vitro optical molecular imaging solutions for life science and molecular biology research.

Carigent Therapeutics has developed a novel technology for attaching very high densities of application-specific molecules to the surfaces of biodegradable, polymeric particles ranging in size from tens of nanometers to hundreds of microns.

The company develops new treatments for cancer based on a portfolio of delivery technologies including liposomes, polymers and nanotechnologies.

Celera has a successful molecular diagnostics business and powerful genomic and proteomic discovery platforms that have identified and validated new drug targets and biomarkers that will advance the practice of Targeted Medicine.

Cell Biosciences creates instrumentation systems, software, and assay products that reveal previously undetectable information about intracellular control pathways.

An instrumentation and cell-based assay company developing technologies that accurately mimic cellular behavior in vivo for cell-based screening in drug discovery.

Celsense is a biotechnology company offering novel MRI contrast agents (fluorochemical nanoparticles) that allow scientists and clinicians to monitor the position and quantity of transplanted cells non-invasively in vivo.

Commercializes a nano and micron sized ceramic spheres technology that provides encapsulation and controlled release of active molecules for a variety of applications including drug delivery, cosmeceuticals and speciality chemicals.

CGI Pharmaceuticals is dedicated to the discovery and development of breakthrough small molecule kinase inhibitors for a broad range of oncology/angiogenesis and autoimmune/allergic/inflammatory disease indications.

The company develops nanoparticle-based gene therapies for eye disease.

Chemicell develops and produces innovative bioseparation- gene transfection and detection systems based on magnetic nano- and microparticles.

Chemicon offers molecular biology research tools. Included are mRNA expression analysis assays via RT-PCR and PCR amplication methods for apoptosis, cancer, cytokines, signal transduction, MMPs and ECM using colorimetric or bioluminescent formats

Focused on the development and manufacture of proteins for human therapy.

The company has created a technology platform to design nano-composites and nano-structured materials for coatings for biomedical applications.

Concurrent Analytical is developing the Ramanprobes technology - a revolutionary new method in point-of-care diagnostics that enables the possibility to detect and identify multiple cancer biomarkers concurrently in seconds, at the sensitivity and specificity necessary for early cancer diagnosis.

Developed a technology to compact DNA into complexes containing only a single molecule of DNA, resulting in a volume 30-1000 times smaller than other complexes. This simple difference makes Copernicus' "DNA nanoparticles" highly stable and uniquely able to deliver DNA to the nuclei of non-dividing human cells - which includes most cells in the body.

A smart sensor materials company developing responsive, conductive polymers for detecting biological and chemical analytes.

Develops the Emulsiphan™ nanoparticle tumor targeting technology.